Board recommends Final Dividend
Caplin Point Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on November 21, 2011, inter alia, has Recommended a final Dividend of Re. 1.50 per share (15%) on the equity capital for the year ended June 30, 2011. Board to consider Dividend
Caplin Point Laboratories Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on November 21, 2011, inter alia, to consider the Audited Financial Results of the Company for the year ended June 30, 2011 and to consider the declaration of Dividend, if any. Appointment of Director
Caplin Point Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on October 31, 2011, has appointed Mr. N. R. Achan, as an Additional Director on the Board of the Company. Mr. N. R. Achan is a distinguished Senior Banker and former Chairman of Catholic Syrian Bank and will serve as a Non Executive Independent Director on the Board of the Company. Outcome of Board Meeting
Caplin Point Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on October 31, 2011, has appointed Mr. L. Balasubramanian, as the Vice President - Corporate Affairs of the Company. Financial Results for Sep 30, 2011
Caplin Point Laboratories Ltd has informed BSE about the Financial Results for the period ended September 30, 2011. Updates
Caplin Point Laboratories Ltd has informed BSE that Mr. B. Philip Ashok Karunakaran, a senior quality control professional having rich and varied experience in Quality Control and Quality Assurance has been appointed to the position of Head - Corporate Quality Control / Quality Assurance of Caplin Point Laboratories Ltd. from September 02, 2011 and he shall be in overall charge of the Quality function of the Company from the said date. Appointment of Senior Executive
Caplin Point Laboratories Ltd has informed BSE that the Board of Directors, at their meeting held on July 30, 2011, have appointed Mr. Vivek Siddharth as the Chief Operating Officer of the Company w.e.f. August 01, 2011 Mr. Vivek Siddarth has more than 5 years of experience in the Pharmaceutical industry. Financial Results for June 30, 2011
Caplin Point Laboratories Ltd has informed BSE about the Financial Results for the period ended June 30, 2011. Change in Directorate
Caplin Point Laboratories Ltd has informed BSE that the Board of Directors of the Company have by means of a Circular resolution passed on June 28, 2011 accepted the resignation of Ms. R. Sriranjini, from the position of Company Secretary, with effect from June 30, 2011 and appointed Mr. T. V. Thulsidass, a qualified Company Secretary, to the said position with effect from July 01, 2011 appointed Mr. Venkat Radhakrishnan as Additional Director from July 01, 2011.